Clinical Trials
3 trialsNCT07064330 2025-09-10
NGF-GRACE
Instituto de Investigación Biomédica de Salamanca
Recruiting
NCT07100925 2025-08-03
A Study of Tolododekin Alfa (ANK-101) in Renal Allograft Recipients With High Risk Cutaneous Squamous Cell Carcinoma
Ankyra Therapeutics, Inc
Phase 1 Not yet recruiting
NCT06823479 2025-05-29
MATISSE 2
The Netherlands Cancer Institute
Phase 2 Recruiting